BioNTech SE

Biotechnology company · Mainz, Rheinland-Pfalz, Germany · Nasdaq: BNTX

BioNTech SE is a biotechnology company headquartered in Mainz, Rheinland-Pfalz, Germany. Its shares trade on Nasdaq under the ticker BNTX. It has reported private securities offerings to the US SEC, most recently $150 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

BioNTech SE at a glance

Typebiotechnology company
HeadquartersMainz, Rheinland-Pfalz, Germany
Stock listingNasdaq: BNTX
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1776985

What does BioNTech SE do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $150 million sold (2022).

Frequently asked questions about BioNTech SE

Where is BioNTech SE headquartered?

BioNTech SE is headquartered in Mainz, Rheinland-Pfalz, Germany.

What does BioNTech SE do?

BioNTech SE is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is BioNTech SE a public company?

Yes. BioNTech SE trades on Nasdaq under the ticker BNTX.

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.